NCT05271604
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05271604
Title A Phase 2 Open Label Study of BA3021 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors BioAtla, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
USC Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
Christiana Care Helen Graham Cancer Center Newark Delaware 19713 United States Details
Northwestern University Chicago Illinois 60611 United States Details
Norton Cancer Institute Louisville Kentucky 40202 United States Details
Washington University Medical Siteman Cancer Center St Louis Missouri 63110 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field